Literature DB >> 31812517

Intravascular ultrasound or optical coherence tomography-defined anatomic severity and hemodynamic severity assessed by coronary physiologic indices.

Joo Myung Lee1, Ki Hong Choi1, Bon-Kwon Koo2, Jinlong Zhang3, Jung-Kyu Han3, Han-Mo Yang3, Kyung Woo Park3, Young Bin Song1, Joo-Yong Hahn1, Seung-Hyuk Choi1, Hyeon-Cheol Gwon1, Hyo-Soo Kim3.   

Abstract

INTRODUCTION AND
OBJECTIVES: Fractional flow reserve or instantaneous wave-free ratio has become a standard criterion for revascularization. We sought to evaluate the association between intravascular ultrasound (IVUS) or optical coherence tomography (OCT)-derived quantitative plaque characteristics and the severity of physiologic stenosis.
METHODS: A total of 365 stenoses from 330 patients were evaluated. The association between IVUS or OCT-derived parameters and resting physiologic indices (instantaneous wave-free ratio, resting full-cycle ratio, and diastolic pressure ratio) and fractional flow reserve were explored.
RESULTS: Among the total number of lesions, 50.7% and 58.1% showed an instantaneous wave-free ratio ≤ 0.89 and fractional flow reserve ≤ 0.80, respectively. IVUS or OCT-derived parameters showed significant correlations with resting physiologic indices (P values <.005). The best cutoff values of IVUS minimum lumen area (MLA), plaque burden, OCT-MLA, and OCT-area stenosis to predict functional significance were the same (IVUS-MLA: 3.4 mm2, plaque burden: 72.0%, OCT-MLA: 2.0 mm2, OCT-area stenosis: 68.0%) for all resting physiologic indices (instantaneous wave-free ratio, resting full-cycle ratio, and diastolic pressure ratio). The best cutoff values for fractional flow reserve were an IVUS-MLA of 3.8 mm2, plaque burden of 70.0%, OCT-MLA of 2.3 mm2, and OCT-area stenosis of 65.0%. Regardless of IVUS or OCT-derived parameters, the overall diagnostic accuracies of the parameters were lower than 70% and discrimination indices were less than 0.75 for resting physiologic indices or fractional flow reserve.
CONCLUSIONS: The resting physiologic indices showed an identical relationship with IVUS or OCT-defined quantitative plaque characteristics. The diagnostic accuracy and discrimination ability of anatomical parameters were modest in predicting functional significance defined by resting and hyperemic invasive physiologic indices. This trial is registered at ClinicalTrials.gov (Identifier: NCT03795714).
Copyright © 2019 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Diastolic pressure ratio; Ecocardiografía intravascular; Enfermedad arterial coronaria; Fractional flow reserve; Instantaneous wave-free ratio; Intravascular ultrasound; Ischemia; Isquemia; Relación de ciclo completo en reposo; Relación de presión diastólica; Relación instantánea de onda libre; Reserva fraccional de flujo; Resting full-cycle ratio

Year:  2019        PMID: 31812517     DOI: 10.1016/j.rec.2019.11.001

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  2 in total

1.  Prognostic Implication of Non-Obstructive Coronary Lesions: A New Classification in Different Settings.

Authors:  Jorge Rodríguez-Capitán; Andrés Sánchez-Pérez; Sara Ballesteros-Pradas; Mercedes Millán-Gómez; Rosa Cardenal-Piris; Manuel Oneto-Fernández; Lola Gutiérrez-Alonso; Ricardo Rivera-López; Agustín Guisado-Rasco; Macarena Cano-García; Mario Gutiérrez-Bedmar; Manuel Jiménez-Navarro
Journal:  J Clin Med       Date:  2021-04-25       Impact factor: 4.241

2.  Long-Term Clinical Outcomes of Nonhyperemic Pressure Ratios: Resting Full-Cycle Ratio, Diastolic Pressure Ratio, and Instantaneous Wave-Free Ratio.

Authors:  Joo Myung Lee; Seung Hun Lee; Doyeon Hwang; Tae-Min Rhee; Ki Hong Choi; Jinseob Kim; Jinhyoung Park; Hyung Yoon Kim; Hae Won Jung; Yun-Kyeong Cho; Hyuck-Jun Yoon; Young Bin Song; Joo-Yong Hahn; Chang-Wook Nam; Eun-Seok Shin; Joon-Hyung Doh; Seung-Ho Hur; Bon-Kwon Koo
Journal:  J Am Heart Assoc       Date:  2020-09-11       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.